Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cataract Extraction | 5 | 2014 | 32 | 0.740 |
Why?
|
| Orbit | 2 | 2017 | 38 | 0.560 |
Why?
|
| Orbital Cellulitis | 1 | 2017 | 4 | 0.540 |
Why?
|
| Glucocorticoids | 2 | 2017 | 369 | 0.540 |
Why?
|
| Toxoplasmosis, Congenital | 7 | 2015 | 49 | 0.540 |
Why?
|
| Cataract | 5 | 2011 | 87 | 0.470 |
Why?
|
| Diplopia | 1 | 2013 | 13 | 0.400 |
Why?
|
| Retinal Detachment | 2 | 2020 | 60 | 0.380 |
Why?
|
| Toxoplasmosis, Ocular | 5 | 2011 | 17 | 0.360 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 264 | 0.340 |
Why?
|
| Lens Implantation, Intraocular | 2 | 2014 | 24 | 0.330 |
Why?
|
| Toxoplasma | 4 | 2017 | 120 | 0.330 |
Why?
|
| Pain | 1 | 2013 | 426 | 0.330 |
Why?
|
| Uveitis | 2 | 2003 | 35 | 0.310 |
Why?
|
| Glaucoma | 2 | 2014 | 36 | 0.300 |
Why?
|
| Toxoplasmosis | 2 | 2017 | 70 | 0.230 |
Why?
|
| Infant | 11 | 2020 | 3359 | 0.230 |
Why?
|
| Nystagmus, Pathologic | 2 | 2002 | 37 | 0.220 |
Why?
|
| Adolescent | 11 | 2017 | 9878 | 0.210 |
Why?
|
| Antibodies, Protozoan | 4 | 2017 | 46 | 0.200 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 2 | 0.200 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2003 | 6 | 0.190 |
Why?
|
| Child, Preschool | 10 | 2015 | 3969 | 0.190 |
Why?
|
| Lens, Crystalline | 1 | 2003 | 67 | 0.180 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1618 | 0.180 |
Why?
|
| Child | 12 | 2015 | 7621 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 355 | 0.160 |
Why?
|
| Vitreous Body | 3 | 2011 | 54 | 0.160 |
Why?
|
| Immunoglobulin M | 2 | 2017 | 164 | 0.150 |
Why?
|
| Antiprotozoal Agents | 3 | 2008 | 31 | 0.150 |
Why?
|
| Immunoglobulin G | 3 | 2017 | 481 | 0.150 |
Why?
|
| Eye Diseases | 3 | 2011 | 59 | 0.150 |
Why?
|
| Retinopathy of Prematurity | 1 | 2020 | 75 | 0.150 |
Why?
|
| Visual Acuity | 5 | 2008 | 209 | 0.150 |
Why?
|
| Postoperative Complications | 2 | 2014 | 2603 | 0.140 |
Why?
|
| Infant, Newborn | 7 | 2020 | 2611 | 0.140 |
Why?
|
| Point-of-Care Testing | 1 | 2017 | 28 | 0.130 |
Why?
|
| Immunoassay | 1 | 2017 | 100 | 0.130 |
Why?
|
| Female | 16 | 2017 | 49980 | 0.130 |
Why?
|
| Ataxia | 1 | 1997 | 47 | 0.120 |
Why?
|
| Tolmetin | 1 | 1996 | 1 | 0.120 |
Why?
|
| Tromethamine | 1 | 1996 | 4 | 0.120 |
Why?
|
| Aqueous Humor | 1 | 1996 | 21 | 0.120 |
Why?
|
| Retrospective Studies | 7 | 2020 | 10307 | 0.120 |
Why?
|
| Family Health | 1 | 2015 | 159 | 0.110 |
Why?
|
| Vision Disorders | 3 | 2011 | 72 | 0.110 |
Why?
|
| Humans | 22 | 2020 | 95992 | 0.110 |
Why?
|
| Hydrocephalus | 1 | 2015 | 108 | 0.110 |
Why?
|
| Fathers | 1 | 2015 | 82 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 393 | 0.110 |
Why?
|
| Aphakia, Postcataract | 2 | 2005 | 4 | 0.100 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2014 | 26 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 249 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3642 | 0.100 |
Why?
|
| Methylprednisolone | 1 | 2013 | 68 | 0.100 |
Why?
|
| Incidence | 5 | 2015 | 1723 | 0.100 |
Why?
|
| Leg | 1 | 2013 | 143 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 420 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2005 | 3922 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 905 | 0.090 |
Why?
|
| Genotype | 1 | 2015 | 1883 | 0.080 |
Why?
|
| Retinal Diseases | 2 | 2011 | 84 | 0.080 |
Why?
|
| Recurrence | 4 | 2011 | 1231 | 0.080 |
Why?
|
| Male | 12 | 2015 | 45792 | 0.070 |
Why?
|
| Retinal Hemorrhage | 1 | 2008 | 9 | 0.070 |
Why?
|
| Chorioretinitis | 1 | 2008 | 9 | 0.070 |
Why?
|
| Choroidal Neovascularization | 1 | 2008 | 23 | 0.070 |
Why?
|
| Risk Factors | 4 | 2014 | 5992 | 0.070 |
Why?
|
| Pregnancy | 4 | 2015 | 3239 | 0.070 |
Why?
|
| Pyrimethamine | 4 | 2008 | 21 | 0.060 |
Why?
|
| Sulfadiazine | 4 | 2008 | 24 | 0.060 |
Why?
|
| Saudi Arabia | 1 | 2005 | 17 | 0.060 |
Why?
|
| Lenses, Intraocular | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2006 | 244 | 0.050 |
Why?
|
| Adult | 7 | 2008 | 28636 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2015 | 3115 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2004 | 63 | 0.050 |
Why?
|
| Leucovorin | 3 | 2008 | 215 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2003 | 63 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2003 | 71 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 380 | 0.050 |
Why?
|
| Endophthalmitis | 1 | 2003 | 19 | 0.050 |
Why?
|
| Eyeglasses | 1 | 2002 | 8 | 0.050 |
Why?
|
| Brain | 1 | 2013 | 2479 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 1425 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2003 | 163 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2002 | 318 | 0.040 |
Why?
|
| Drug Therapy, Combination | 3 | 2008 | 789 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2004 | 983 | 0.040 |
Why?
|
| Laser Coagulation | 1 | 2020 | 55 | 0.040 |
Why?
|
| Prevalence | 2 | 2015 | 1355 | 0.040 |
Why?
|
| Alleles | 2 | 2014 | 1157 | 0.040 |
Why?
|
| Gestational Age | 1 | 2020 | 343 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2020 | 275 | 0.040 |
Why?
|
| Age Factors | 1 | 2004 | 1959 | 0.040 |
Why?
|
| Prognosis | 1 | 2005 | 3993 | 0.030 |
Why?
|
| Strabismus | 1 | 1997 | 10 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 1997 | 12 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 64 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 157 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 91 | 0.030 |
Why?
|
| Electroretinography | 1 | 1997 | 80 | 0.030 |
Why?
|
| United States | 3 | 2017 | 7785 | 0.030 |
Why?
|
| Ketorolac Tromethamine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Ketorolac | 1 | 1996 | 6 | 0.030 |
Why?
|
| Ionophores | 1 | 1996 | 14 | 0.030 |
Why?
|
| Ophthalmic Solutions | 1 | 1996 | 14 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 1996 | 66 | 0.030 |
Why?
|
| Conjunctiva | 1 | 1996 | 17 | 0.030 |
Why?
|
| Agglutination Tests | 1 | 2015 | 12 | 0.030 |
Why?
|
| Serogroup | 1 | 2015 | 12 | 0.030 |
Why?
|
| Rabbits | 1 | 1996 | 639 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2008 | 4690 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2014 | 20 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2014 | 65 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2008 | 1176 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1006 | 0.030 |
Why?
|
| Plasmids | 1 | 2014 | 291 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 256 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 385 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2042 | 0.020 |
Why?
|
| Monocytes | 1 | 2014 | 219 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1996 | 712 | 0.020 |
Why?
|
| Serotyping | 1 | 2012 | 28 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 562 | 0.020 |
Why?
|
| Uveitis, Anterior | 1 | 2011 | 5 | 0.020 |
Why?
|
| Choroiditis | 1 | 2011 | 8 | 0.020 |
Why?
|
| Optic Nerve Diseases | 1 | 2011 | 16 | 0.020 |
Why?
|
| Virulence | 1 | 2012 | 279 | 0.020 |
Why?
|
| Brazil | 1 | 2011 | 83 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1505 | 0.020 |
Why?
|
| Middle Aged | 2 | 2003 | 28299 | 0.020 |
Why?
|
| Cicatrix | 1 | 2011 | 77 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 1014 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 871 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2536 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2002 | 9228 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 2534 | 0.020 |
Why?
|
| Ranibizumab | 1 | 2008 | 19 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2008 | 83 | 0.020 |
Why?
|
| Injections | 1 | 2008 | 127 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2008 | 131 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2014 | 1424 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2006 | 21 | 0.020 |
Why?
|
| Vision, Monocular | 1 | 2006 | 15 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2006 | 39 | 0.020 |
Why?
|
| Macula Lutea | 1 | 2006 | 17 | 0.020 |
Why?
|
| Language Tests | 1 | 2006 | 39 | 0.020 |
Why?
|
| Vision, Binocular | 1 | 2006 | 21 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 5593 | 0.010 |
Why?
|
| Inflammation | 1 | 2011 | 1063 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2006 | 162 | 0.010 |
Why?
|
| Animals | 2 | 2008 | 28901 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2008 | 1021 | 0.010 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2000 | 16 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2000 | 45 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2000 | 110 | 0.010 |
Why?
|